APO RESEARCH · REPORT
Amifostine
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
Product & engineering
Understand the product.
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
Selected research
Industry Research
Amifostine Industry Research Report 2026
Market perspective
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share over 40 percent.
Report Scope
Read the full market overview
This report quantifies the global Amifostine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Amifostine Market by Company
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Amifostine Segment by Type
400mg/Dose
500mg/Dose
Amifostine Segment by Application
Head and Neck Cancer Adjuvant Therapy
Others
Amifostine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amifostine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amifostine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amifostine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Amifostine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Amifostine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Amifostine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 400mg/Dose
- 500mg/Dose
Applications
- Head and Neck Cancer Adjuvant Therapy
- Others
Companies covered
- Clinigen
- Sun Pharmaceutical
- Taj Pharmaceuticals
- Merro Pharmaceutical
- Luye Pharma
- Mingren Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Amifostine Market Size (2021-2032)
- 2.2.2 Global Amifostine Sales (2021-2032)
- 2.2.3 Global Amifostine Market Average Price (2021-2032)
- 2.3 Amifostine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 400mg/Dose
- 2.3.3 500mg/Dose
- 2.4 Amifostine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Head and Neck Cancer Adjuvant Therapy
- 2.4.3 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Amifostine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Amifostine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Amifostine Revenue of Manufacturers (2021-2026)
- 3.4 Global Amifostine Average Price by Manufacturers (2021-2026)
- 3.5 Global Amifostine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Amifostine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Amifostine, Product Type & Application
- 3.8 Global Manufacturers of Amifostine, Established Date
- 3.9 Global Amifostine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Clinigen
- 4.1.1 Clinigen Company Information
- 4.1.2 Clinigen Business Overview
- 4.1.3 Clinigen Amifostine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Clinigen Amifostine Product Portfolio
- 4.1.5 Clinigen Recent Developments
- 4.2 Sun Pharmaceutical
- 4.2.1 Sun Pharmaceutical Company Information
- 4.2.2 Sun Pharmaceutical Business Overview
- 4.2.3 Sun Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharmaceutical Amifostine Product Portfolio
- 4.2.5 Sun Pharmaceutical Recent Developments
- 4.3 Taj Pharmaceuticals
- 4.3.1 Taj Pharmaceuticals Company Information
- 4.3.2 Taj Pharmaceuticals Business Overview
- 4.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Taj Pharmaceuticals Amifostine Product Portfolio
- 4.3.5 Taj Pharmaceuticals Recent Developments
- 4.4 Merro Pharmaceutical
- 4.4.1 Merro Pharmaceutical Company Information
- 4.4.2 Merro Pharmaceutical Business Overview
- 4.4.3 Merro Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merro Pharmaceutical Amifostine Product Portfolio
- 4.4.5 Merro Pharmaceutical Recent Developments
- 4.5 Luye Pharma
- 4.5.1 Luye Pharma Company Information
- 4.5.2 Luye Pharma Business Overview
- 4.5.3 Luye Pharma Amifostine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Luye Pharma Amifostine Product Portfolio
- 4.5.5 Luye Pharma Recent Developments
- 4.6 Mingren Pharma
- 4.6.1 Mingren Pharma Company Information
- 4.6.2 Mingren Pharma Business Overview
- 4.6.3 Mingren Pharma Amifostine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mingren Pharma Amifostine Product Portfolio
- 4.6.5 Mingren Pharma Recent Developments
5 Global Amifostine Market Scenario by Region
- 5.1 Global Amifostine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Amifostine Sales by Region: 2021-2032
- 5.2.1 Global Amifostine Sales by Region: 2021-2026
- 5.2.2 Global Amifostine Sales by Region: 2027-2032
- 5.3 Global Amifostine Revenue by Region: 2021-2032
- 5.3.1 Global Amifostine Revenue by Region: 2021-2026
- 5.3.2 Global Amifostine Revenue by Region: 2027-2032
- 5.4 North America Amifostine Market Facts & Figures by Country
- 5.4.1 North America Amifostine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Amifostine Sales by Country (2021-2032)
- 5.4.3 North America Amifostine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Amifostine Market Facts & Figures by Country
- 5.5.1 Europe Amifostine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Amifostine Sales by Country (2021-2032)
- 5.5.3 Europe Amifostine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Amifostine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Amifostine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Amifostine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Amifostine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Amifostine Market Facts & Figures by Country
- 5.7.1 South America Amifostine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Amifostine Sales by Country (2021-2032)
- 5.7.3 South America Amifostine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Amifostine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Amifostine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Amifostine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Amifostine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Amifostine Sales by Type (2021-2032)
- 6.1.1 Global Amifostine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Amifostine Sales Market Share by Type (2021-2032)
- 6.2 Global Amifostine Revenue by Type (2021-2032)
- 6.2.1 Global Amifostine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Amifostine Revenue Market Share by Type (2021-2032)
- 6.3 Global Amifostine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Amifostine Sales by Application (2021-2032)
- 7.1.1 Global Amifostine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Amifostine Sales Market Share by Application (2021-2032)
- 7.2 Global Amifostine Revenue by Application (2021-2032)
- 7.2.1 Global Amifostine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Amifostine Revenue Market Share by Application (2021-2032)
- 7.3 Global Amifostine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Amifostine Value Chain Analysis
- 8.1.1 Amifostine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Amifostine Production Mode & Process
- 8.2 Amifostine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Amifostine Distributors
- 8.2.3 Amifostine Customers
9 Global Amifostine Analyzing Market Dynamics
- 9.1 Amifostine Industry Trends
- 9.2 Amifostine Industry Drivers
- 9.3 Amifostine Industry Opportunities and Challenges
- 9.4 Amifostine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst